, whereas PP/CNTs were obtained by the condensation of terephthaldehyde and pyrrole in the presence of CNTs. The Ru-PP/CNTs have a thin layer of highly cross-linked polymeric ruthenium porphyrin coating over the CNT surface via strong π-π stacking interactions, thus showing a bilayered structure with an amorphous polymeric outer surface and an internal CNT core. Polymeric ruthenium porphyrin-functionalized reduced graphene oxide (Ru-PP/RGO) was prepared with a synthetic procedure similar to Ru-PP/CNTs, with RGO as the internal core. Both Ru-PP/CNTs and Ru-PP/RGO showed excellent catalytic performance toward hydrogenation of biomass-related ethyl levulinate (EL) to γ-valerolactone (GVL) with Ru-centered porphyrin units as the catalytic active species. Under optimized reaction conditions, a GVL yield higher than 99% with a complete conversion of EL was observed over both Ru-PP/CNTs and Ru-PP/RGO. In addition to GVL preparation, the versatile Ru-PP/CNTs can efficiently promote reductive amination of EL with various amines for the synthesis of pyrrolidone derivatives, with the corresponding yields ranging from 96.3 to 88.7%. Moreover, the composite materials of both Ru-PP/CNTs and Ru-PP/RGO behave as heterogeneous catalysts in the reaction system and can be easily reused.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: